⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21191548 | 1.00 | — | — | |
| SCHEMBL21191550 | 0.71 | — | — | |
| SCHEMBL16840166 | 0.66 | — | — | |
| SCHEMBL22024156 | 0.64 | — | — | |
| SCHEMBL13761479 | 0.62 | — | — | |
| SCHEMBL12213701 | 0.60 | — | — | |
| SCHEMBL12712143 | 0.60 | — | — | |
| SCHEMBL22778841 | 0.60 | — | — | |
| SCHEMBL11411985 | 0.58 | — | — | |
| SCHEMBL12679240 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865211-B2 | Functionalized heterocycles as antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| US-20200095258-A1 | FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2020-03-26 | — | — | US | disclosed |